The influence of estrogen treatment on induction of mammary carcinoma in rats by single-dose gamma irradiation at different ages.

The effect of age at exposure on induction of mammary carcinoma was studied in female rats of the inbred WAG/Rij strain that were treated with estrogen. Groups of 40 animals were exposed to a single total-body dose of 1 or 2 Gy of 137Cs gamma radiation at age 8, 10, 12, 15, 22, 36 or 64 weeks. Hormone levels in the animals were increased by implantation of a pellet containing Estradiol-17beta 2 weeks prior to irradiation. Animals were killed when moribund. All mammary tumors were resected and classified histologically as carcinoma or fibroadenoma. The age-specific incidence of mammary carcinoma was compared with that in control groups of unirradiated estrogen-treated rats using lifetime statistical analysis with both parametric and nonparametric methods. The excess normalized risk of carcinoma was 7.7 for both 1 and 2 Gy in the age groups 8-15 weeks, with no significant differences between the age groups. However, in the age groups 22-64 weeks, the excess normalized risk decreased with increasing age at exposure. Irradiation at 64 weeks yielded fewer carcinomas than in the controls, with an excess normalized risk of -0.6 for both 1 and 2 Gy. The excess normalized risk was 10-80 in estrogen-treated controls compared to untreated rats. The present data agree with the results reported previously for estrogen-treated rats irradiated at ages 8 or 17 weeks with doses of 0.3 or 1.2 Gy. The reduced risk of radiation exposure at midlife observed in this study in hormone-treated rats has also been reported for animals not treated with estrogens. The present findings support the earlier conclusion that radiological screening for mammary cancer after the age of menopause will not increase the normal incidence of breast cancer. Estrogen treatment at midlife may increase the risk of breast cancer in women using replacement estrogens during and after menopause.

[1]  J. Zoetelief,et al.  Induction of mammary tumors in rats by single-dose gamma irradiation at different ages. , 1998, Radiation research.

[2]  J. Zoetelief,et al.  Assessment of lifetime gained as a result of mammographic breast cancer screening using a computer model. , 1997, The British journal of radiology.

[3]  J Zoetelief,et al.  Optimisation of mammographic breast cancer screening using a computer simulation model. , 1997, European journal of radiology.

[4]  László Tabár,et al.  Quantitative Interpretation of Age-Specific Mortality Reductions From the Swedish Breast Cancer-Screening Trials , 1995 .

[5]  G R Howe,et al.  Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. , 1995, Radiation research.

[6]  J. Zoetelief,et al.  MBS: a model for risk benefit analysis of breast cancer screening. , 1995, The British journal of radiology.

[7]  C. Land,et al.  Incidence of female breast cancer among atomic bomb survivors, 1950-1985. , 1994, Radiation research.

[8]  S Shapiro,et al.  Report of the International Workshop on Screening for Breast Cancer. , 1993, Journal of the National Cancer Institute.

[9]  P. Hall,et al.  Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease. , 1993, Journal of the National Cancer Institute.

[10]  S. Wall,et al.  Breast cancer screening with mammography: overview of Swedish randomised trials , 1993, The Lancet.

[11]  S. Hancock,et al.  Breast Cancer After Treatment of Hodgkin's Disease , 1993 .

[12]  H A Risch,et al.  Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. , 1989, The New England journal of medicine.

[13]  J. J. Broerse,et al.  Mammary carcinogenesis in different rat strains after irradiation and hormone administration. , 1987, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[14]  M. J. Zwieten The Rat as Animal Model in Breast Cancer Research: A histopathological study of radiation- and hormone-induced rat mammary tumors , 1984 .

[15]  P. Sylvester,et al.  Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats. , 1983, Cancer research.

[16]  D. Papworth,et al.  The dose-response for x-ray induction of myeloid leukaemia in male CBA/H mice. , 1983, British Journal of Cancer.

[17]  M. Blankenstein,et al.  Oestrogen receptors in rat mammary tissue and plasma concentrations of prolactin during mammary carcinogenesis induced by oestrogen and ionizing radiation. , 1981, The Journal of endocrinology.

[18]  Owen Ln A comparative study of canine and human breast cancer. , 1979 .

[19]  M. Blankenstein,et al.  The effect of subcutaneous administration of oestrogens on plasma oestrogen levels and tumour incidence in female rats. , 1977, European journal of cancer.

[20]  Poel We Progesterone enhancement of mammary tumor development as a model of co-carcinogenesis. , 1968 .

[21]  M. Klauber,et al.  Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. , 1968, Journal of the National Cancer Institute.

[22]  L. Boot,et al.  The mode of action of ovarian hormones in the induction of mammary cancer in mice. , 1967, Biochemical pharmacology.

[23]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[24]  J. Davelaar,et al.  Analysis of animal carcinogenesis data by various mathematical methods , 1991, Radiation and environmental biophysics.

[25]  J. J. Broerse,et al.  The gene transfer-misrepair hypothesis of radiation carcinogenesis tested for induction of mammary tumours in rats. , 1986, Leukemia research.

[26]  J. Hilgers,et al.  Genetic analysis of mammary tumor induction and expression of mammary tumor virus antigen in hormone-treated ovariectomized GR mice. , 1976, Journal of the National Cancer Institute.